Zydus to launch OxemiaTM a breakthrough treatment for Anemia in patients suffering from Chronic Kidney Disease

Zydus to launch OxemiaTM (Desidustat) a breakthrough treatment for Anemia in patients suffering from Chronic Kidney Disease. Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.), a discovery-driven, global lifesciences company … Read More

Zydus starts phase 2(b) clinical trials of Saroglitazar Mg in Primary Biliary Cholangitis

Zydus, a leading discovery based, global pharmaceutical company today announced that it has received permission from the USFDA to initiate the Phase 2(b)/3 Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled adaptive clinical trial to evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects With … Read More

Gland Pharma’s Q2FY22 Revenue grew by 30% with Net Profit growth of 38%

Gland Pharma’s  Q2FY22  Revenue  grew  by  30%  with  Net  Profit  growth  of  38%. Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable focused pharmaceutical company, today announced its financial results for the second quarter and half year ended September 30, … Read More